Verastem Stock Annual Yield
VSTM Stock | USD 5.33 0.05 0.95% |
Verastem fundamentals help investors to digest information that contributes to Verastem's financial success or failures. It also enables traders to predict the movement of Verastem Stock. The fundamental analysis module provides a way to measure Verastem's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Verastem stock.
Verastem |
Verastem Company Annual Yield Analysis
Verastem's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Verastem has an Annual Yield of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
All Next | Launch Module |
Verastem Fundamentals
Return On Equity | -1.37 | ||||
Return On Asset | -0.47 | ||||
Operating Margin | (11.45) % | ||||
Current Valuation | 186.63 M | ||||
Shares Outstanding | 44.51 M | ||||
Shares Owned By Insiders | 1.08 % | ||||
Shares Owned By Institutions | 59.97 % | ||||
Number Of Shares Shorted | 3.09 M | ||||
Price To Earning | (3.02) X | ||||
Price To Book | 21.45 X | ||||
Price To Sales | 23.72 X | ||||
Gross Profit | 10 M | ||||
EBITDA | (83.17 M) | ||||
Net Income | (87.37 M) | ||||
Cash And Equivalents | 94.31 M | ||||
Cash Per Share | 0.50 X | ||||
Total Debt | 41.56 M | ||||
Debt To Equity | 0.50 % | ||||
Current Ratio | 4.87 X | ||||
Book Value Per Share | 0.28 X | ||||
Cash Flow From Operations | (86.46 M) | ||||
Short Ratio | 1.74 X | ||||
Earnings Per Share | (3.14) X | ||||
Price To Earnings To Growth | (1.89) X | ||||
Target Price | 12.29 | ||||
Number Of Employees | 73 | ||||
Beta | 0.14 | ||||
Market Capitalization | 237.22 M | ||||
Total Asset | 149.72 M | ||||
Retained Earnings | (824.89 M) | ||||
Working Capital | 117.3 M | ||||
Current Asset | 110.84 M | ||||
Current Liabilities | 10.11 M | ||||
Net Asset | 149.72 M |
About Verastem Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Verastem's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Verastem using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Verastem based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Verastem Piotroski F Score and Verastem Altman Z Score analysis. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Verastem listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Verastem's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.